Published On: Sat, Apr 18th, 2020

Uterine Cancer Diagnostic Testing Market to Record CAGR 7.8% Increase in Revenue By 2026

In a recent study on the global uterine cancer diagnostic testing market, leading research firm Persistence Market Research has tracked the growth path of the global market for uterine cancer diagnostic testing over an eight-year period from 2018 to 2026.

The report features global market numbers and insights on the various factors driving the adoption of advanced uterine cancer diagnostic tests. According to the report, two of the main aspects responsible for a surge in revenue in the global uterine cancer diagnostic testing market are – a rising awareness among the female population pertaining to the various diseases of the uterus, and the availability of different types of direct and combination tests to detect uterine cancer.

Persistence Market Research forecasts revenue in the global uterine cancer diagnostic testing market to reach around US$ 3.8 Bn by 2026 end, up from an estimated value of about US$ 2 Bn in 2018. The market is expected to witness a growth rate of 7.8% during the eight-year period from 2018 to 2026.

Uterine Cancer Diagnostic Testing Market

Persistence Market Research analysis indicates that the glycoproteins CA19.9, YKL-40, CA72.4, and CA15.3 are useful markers that help in the diagnosis of patients suffering from endometrial cancer and may provide a wide opportunity as advanced and improved tumor marker tests for uterine cancer diagnostic testing in the coming years.

Early detection of endometrial cancer in women with irregular and post-menopausal bleeding (one of the early symptoms of endometrial carcinoma) is also likely to elevate the market for uterine cancer diagnostic testing. BRCA1 and BRCA2 breast cancer mutations are related to the spread of endometrial cancer in women. Numerous Tumor Marker Tests Currently Used to Detect Uterine Cancer to Provide a Wide Window of Opportunity in the Global Market

Ongoing research studies that have linked uterine cancer and BRCA mutation indicate favorable outcomes for early-stage diagnosis and prevention of endometrial cancer, by suggesting a uterine diagnosis post the diagnosis of BRCA1 mutation. This is also anticipated to be a good opportunity area in the uterine cancer diagnostic testing market in the near future.

Genetics and Epigenetics Trending the Global Uterine Cancer Diagnostic Testing Market

Gene mutations are fast emerging as candidates in the carcinogenesis of endometrial carcinoma and uterine sarcoma. Gene mutations — including K-ras mutations, PTEN, and β-catenin — are being studied for the diagnosis of uterine cancer. Epigenetic factors such as DNA methylation and histone modification are also being studied to improve the rate of uterine cancer diagnosis.

Advanced genetics and epigenetics are the latest trends being observed in the uterine cancer diagnostic testing market. Another trend is the age standardization of the women population that can help differentiate women from a specific age group who are more prone to developing tumors that may lead to uterine cancer.

A Favorable Reimbursement Scenario to Augur Well for the Global Uterine Cancer Diagnostic Testing Market

Improved reimbursement for uterine cancer diagnostic testing services with co-payment models based on the levels of income of people is a positive development in the global market for uterine cancer diagnostic testing. For instance, Medicare offers good reimbursements for uterine cancer diagnostic testing in the U.S.

The governments across countries in North America have implemented co-payment reimbursement models that can be adjusted as per the income levels of the population. This is benefiting the global uterine cancer diagnostic testing market.

Company Profiles 

  • Abbott
  • Roche Holdings AG
  • Siemens AG
  • Danaher
  • BioMerieux SA
  • Others

Key Research Findings on the Uterine Cancer Diagnostic Testing Market

Persistence Market Research throws light on the top regional growth markets for uterine cancer diagnostic testing; the most prevalent type of uterine cancer; the widely accepted test type to diagnose uterine cancer; and top end users in the uterine cancer diagnostic testing market in this comprehensive research study.

  • North America to remain leading regional market for uterine cancer diagnostic testing, holding over 40% market share by 2026
  • Endometrial carcinoma expected to be the most prevalent cancer type
  • Abdominal ultrasound, hysteroscopy, and CA-125 tumor marker blood test to remain the most preferred test type
  • Diagnostic laboratories anticipated to be the top end-users

Life Sciences & Transformational Health 

Unprecedented access to a world of information has given rise to the empowered, albeit distrustful, consumer. So is the case with healthcare, where the patient has been rendered more informed and conscientious thanks to the extraordinary penetration of the Internet. The discerning patient now demands more affordable, sophisticated, transparent, and personalized healthcare services, creating the need for new models for care.

The advent of health information technology (HIT) components such as electronic health records (EHR), hospital information systems (HIS), picture archiving and communication systems (PACS), and vendor-neutral archives (VNA) has had just as transformational an impact on the overall healthcare sector as the concerns regarding security and privacy. Data theft, undue access to personal health records, and cyber-attacks are very real threats that the healthcare sector faces today.

Get Similar Article about Diagnostics-Healthcare

Shrimp Disease Diagnostics Market

Shrimp processors and exporters worldwide bore the brunt of strict technical barriers concerning disease-free certification requirements that were put in place by importing countries- the Republic of Korea, Australia, China, Saudi Arabia, Mexico, and Brazil.

Such instances led to a substantial increase in the overall adoption rate of effective disease diagnosis and treatment in the shrimp farming space. As the commercialization of shrimp continues on an uphill trajectory, the market was valued at ~ US$ 361.4 Mn in 2018 and is expected to reflect growth at a CAGR of ~ 6.5% during the assessment period.

Infectious Diseases Diagnostics Market

Diagnostics play a vital role in determining the direction of any medical treatment. While infectious diseases diagnostics help in diagnosing diseases caused due to pathogenic infection. The world of diagnostics is evolving rapidly and the global market for infectious diseases diagnostics is growing at a steady pace for the past few years.

The global infectious diseases diagnostics market is predicted to expand at a CAGR of 7.0% over an eight-year forecast period, 2016-2024. The market will reach a value worth US$ 876.6 Mn by 2016 end, up from US$ 827.7 Mn attained in 2015. The revenues are expected to reach US$ 1503.8 Mn by the end of 2024.

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Author: Alicia Haven

Why Mesothelioma Deaths Continue to Rise Despite Preventive Measures

5 Benefits of Wine as World’s Healthiest Wine Hits the UK

3 Advantages Your Business Gains From Promotional Products

On the DISPATCH: Headlines  Local  Opinion

Subscribe to Weekly Newsletter

* indicates required

About the Author

- Outside contributors to the Dispatch are always welcome to offer their unique voices, contradictory opinions or presentation of information not included on the site.

Displaying 1 Comments
Have Your Say

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>



The Global Dispatch Facebook page- click here

Movie News Facebook page - click here

Television News Facebook page - click here

Weird News Facebook page - click here